SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK), First California

  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Kayak
 Software Corporation (KYAK), First California Financial Group, Inc. (FCAL),
Metropolitan Health Networks, Inc. (MDF) and DUSA Pharmaceuticals Inc. (DUSA)

PR Newswire

NEW YORK, Nov. 9, 2012

NEW YORK, Nov. 9, 2012 /PRNewswire/ --

Kayak Software Corporation
Levi & Korsinsky is investigating the Board of Directors of Kayak Software
Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company to
priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would
receive cash and stock valued at approximately $40 per share.

Click here to learn more about the investigation:
http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

First California Financial Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of First California
Financial Group, Inc. (Nasdaq: FCAL) for possible breaches of fiduciary duty
and other violations of state law in connection with the sale of the Company
to PacWest Bancorp (Nasdaq: PACW) for stock valued at approximately $8 per
share.

Click here to learn more about the investigation:
http://zlk.9nl.com/first-california-financial-fcal, or call: 877-363-5972.

Metropolitan Health Networks, Inc.
Levi & Korsinsky is investigating the Board of Directors of Metropolitan
Health Networks, Inc. (NYSE: MDF) for possible breaches of fiduciary duty and
other violations of state law in connection with the sale of the Company to
Humana Inc. (NYSE: HUM) for $11.25 per share. At least one analyst set a price
target for Metropolitan stock at $13.00 per share.

Click here to learn more about the investigation:
http://zlk.9nl.com/metropolitan-health-networks-mdf, or call: 877-363-5972.

DUSA Pharmaceuticals Inc.
Levi & Korsinsky is investigating the Board of Directors of DUSA
Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty
and other violations of state law in connection with the sale of the Company
to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share.

Click here to learn more about the investigation:
http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call: 877-363-5972.

Levi & Korsinsky is a national firm with offices in New York and Washington
D.C. The firm has extensive expertise in prosecuting securities litigation
involving financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Website: http://www.zlk.com